The FDA has promised to review Pfizer’s coronavirus vaccine before the November election, as early as this October. Nicholas Kitchin, M.D., a senior director in Pfizer's vaccine R&D group, told the Centers for Disease Control that the clinical trial of the company’s BioNTech-partnered COVID vaccine, BNT162b2, is more than 50% enrolled. A premium clinical supplies courier, Yourway helps crucial vaccine supplies reach their destinations around the world to facilitate faster trials.